The Serotonin Transporter's Role in Ketamine's Antidepressant Effects.
- Conditions
- 20 patients with severe unipolar depression (structured clinical interview for DSM-IV and the 17-item Hamilton Depression Rating Scale), also 20 age and sex matched healthy controls. plus 12 HC for pilot study I.plus 10 HC for pilot study II.plus 12 HC for pilot study III.plus 30 HC for study sub-study.Drop-outs will be replaced with newly recruited subjects until the number of subjects listed above have completed the study portion they are participating in according to protocol.MedDRA version: 21.1Level: LLTClassification code 10045543Term: Unipolar depressionSystem Organ Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Registration Number
- EUCTR2014-003280-38-AT
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 104
-Men and women aged 18-55
-Participants free from internal medicine or neurologic diseases
-Negative pregnancy test at the screening visit and before PET visits (only women)
-Participants must be willing and able to give informed consent
-Severe unipolar depression tested with a structured clinical interview for DSM-IV (SCID) and HAM-D (only patients)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 104
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
-Severe medical or neurologic disorder
-Psychiatric disorder (only in healthy controls)
-DSM-IV Axis-1 comorbidity other than anxiety symptoms (only patients)
-Clinically relevant alterations in blood draw (hematology, blood chemistry) or standard physical examination
-Addiction to alcohol or another substance (current or past)
-Intake of psychopharmaceutical medication in the last 6 months
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method